MODULO architects is a Brussels-based architecture firm founded in 2000, specializing in contemporary, sustainable designs for complex sectors including research and industry, healthcare, education, and public buildings. With a team of around 20 architects and engineers, the firm has developed deep expertise in laboratory construction, pharmaceutical production units, cleanrooms, bio-incubators, and animal facilities.
Key projects encompass chemistry faculty labs at Université Catholique de Louvain, pharmaceutical expansions for GlaxoSmithKline Biologicals, research centers for AB InBev and VIB, and radioactive labs with cleanrooms at Université de Liège. Recently, MODULO architects collaborated with Tractebel on the design of PanTera's 20,000 m² Actinium-225 production facility in Mol, Belgium, supporting advanced radiopharmaceutical manufacturing for cancer therapies.
None yet. When a new project in the record names Modulo as owner, partner or investor, it shows here.
Consortium to build facility boosting production of a cancer radioisotope; scope includes HVAC, sanitation and technical gases. Construction started; equipment integration planned late 2026.
